EUVIMEDEUVIMED entdecken
Crossref

Maternal–Fetal Results of COVID-19-Infected Pregnant Women Treated with Extracorporeal Membrane Oxygenation: A Descriptive Report

Jorge Luis Alvarado-Socarras, Doris C Quintero-Lesmes, Delia Theurel Martin, Raul Vasquez, Mary Mendoza Monsalve, Lizeth Mogollon Cristancho, Leonardo Salazar Rojas, Jenifer Leon Martinez, Carlos Riaño Medina, Camilo Pizarro Gomez

American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e2115-e2123

DOI: 10.1055/a-2097-1852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Jorge Luis Alvarado-Socarras und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Fundación Cardiovascular de Colombia, Floridablanca, Santander, Colombia. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Pregnancy Complications, Infectious, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

COVID-19 infection may produce severe pneumonia, mainly in the adult population. Pregnant women with severe pneumonia are at high risk of developing complications, and conventional therapy sometimes fails to reverse hypoxemia. Therefore, extracorporeal membrane oxygenation (ECMO) is an option in cases with refractory hypoxemic respiratory failure. This study aims to evaluate the maternal–fetal risk factors, clinical characteristics, complications, and outcomes of 11 pregnant or peripartum patients with COVID-19 treated with ECMO. Study Design This is a retrospective descriptive study of 11 pregnant women undergoing ECMO therapy during the COVID-19 pandemic.

Results

In our cohort, four patients underwent ECMO during pregnancy (36.3%) and 7 during the postpartum period. Initially, they started on venovenous ECMO, and three patients were required to change modality due to clinical conditions. In total, 4/11 pregnant women (36.3%) died. We established two periods that differed in the implementation of a standardized care model for reducing associated morbidities and mortality. Neurological complications were responsible for most deaths. Regarding fetal outcomes at early-stage pregnancies on ECMO (4), we report three stillbirths (75%), and one newborn (twin pregnancy) survived and had a favorable evolution.

Conclusion

At later-stage pregnancies, all newborns survived, and we did not identify any vertical infection. ECMO therapy is an alternative for pregnant women with severe hypoxemic respiratory failure due to COVID-19, and may improve maternal and neonatal results. Regarding fetal outcomes, the gestational age played a definitive role. However, the main complications reported in our series and others are neurological. It is essential to develop novel, future interventions to prevent these complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationPregnancy Complications, InfectiousCOVID-19HumansFemalePregnancyRetrospective StudiesAdultInfant, NewbornSARS-CoV-2Pregnancy OutcomeStillbirth

Autor:innen und Institutionen

  • Department of Pediatrics, Fundación Cardiovascular de Colombia, Floridablanca, Santander, Colombia.
  • Research Center, Investigation Center, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia.
  • Department of Pediatric-Neonatal Critical Care, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia.
  • Department of Critical Care Medicine, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia.
  • ECMO Department, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia.
  • Department of Radiology, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia.

Zitieren

APA

Alvarado-Socarras, J. L., Quintero-Lesmes, D. C., Martin, D. T., Vasquez, R., Monsalve, M. M., Cristancho, L. M., Rojas, L. S., Martinez, J. L., Medina, C. R., & Gomez, C. P. (2024). Maternal–Fetal Results of COVID-19-Infected Pregnant Women Treated with Extracorporeal Membrane Oxygenation: A Descriptive Report. American Journal of Perinatology, 41(S 01 S 01), e2115-e2123. https://doi.org/10.1055/a-2097-1852

Vancouver

Alvarado-Socarras JL, Quintero-Lesmes DC, Martin DT, Vasquez R, Monsalve MM, Cristancho LM, et al. Maternal–Fetal Results of COVID-19-Infected Pregnant Women Treated with Extracorporeal Membrane Oxygenation: A Descriptive Report. American Journal of Perinatology. 2024;41(S 01 S 01):e2115-e2123. doi:10.1055/a-2097-1852

BibTeX
@article{AlvaradoSocarras2024,
  author = {Alvarado-Socarras, Jorge Luis and Quintero-Lesmes, Doris C and Martin, Delia Theurel and Vasquez, Raul and Monsalve, Mary Mendoza and Cristancho, Lizeth Mogollon and Rojas, Leonardo Salazar and Martinez, Jenifer Leon and Medina, Carlos Riaño and Gomez, Camilo Pizarro},
  title = {Maternal–Fetal Results of COVID-19-Infected Pregnant Women Treated with Extracorporeal Membrane Oxygenation: A Descriptive Report},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {S 01 S 01},
  pages = {e2115--e2123},
  doi = {10.1055/a-2097-1852}
}
Kostenlos starten →